CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors

BACKGROUND: To validate the utility of the chemokine ligand 12 (CXCL12) as prognostic marker in patients with localized and metastatic germ cell tumors (GCT). METHODS: CXCL12 expression was analyzed on a tissue microarray consisting of 750 tissue cores of different histological tumor components, Ger...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Principais autores: Fankhauser, Christian Daniel, Roth, Lisa, Grossmann, Nico Christian, Kranzbühler, Benedikt, Eberli, Daniel, Sulser, Tullio, Moch, Holger, Bode, Peter-Karl, Beyer, Joerg, Hermanns, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693197/
https://ncbi.nlm.nih.gov/pubmed/31412792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5961-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados